Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-08-07Clinical Trial Update: Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP [NA]
Clinical trial update shows the Emesis Control Study in Non-Hodgkin lymphoma patients receiving R-CHOP has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of SGI-1776, a PIM kinase inhibitor, in refractory prostate cancer and relapsed/refractory non-Hodgkin lymphoma was terminated…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165 [Phase 2]
This Phase 2 trial update reports long-term follow-up data and thalidomide maintenance outcomes for patients enrolled in Clinical Trial 2003…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Study of AXT-1003 in Adult Subjects With Relapsed/Refractory Non-Hodgkin Lymphomas [Phase 1]
The Phase 1 study of AXT-1003 in adults with relapsed or refractory Non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: The clonoSEQ® Watch Registry
Clinical trial update for the clonoSEQ Watch Registry sponsored by Adaptive Biotechnologies; the study status is terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Vitamin A and D Supplementation in Allogeneic HCT [Phase 2]
Phase 2 clinical trial in allogeneic hematopoietic cell transplantation is evaluating vitamin A and vitamin D supplementation, currently rec…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer [Phase 1]
This Phase 1 dose-escalation trial of taselisib (GDC-0032) in locally advanced or metastatic solid tumors or Non-Hodgkin lymphoma, including…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study [EARLY_Phase 1]
Feasibility early-phase trial evaluating induction and maintenance therapy with avelumab plus R-CHOP in patients with diffuse large B-cell l…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating Imvotamab monotherapy and in combination for relapsed/refractory non-Hodgkin lymphoma has been terminated…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma [Phase 3]
Phase 3 trial update for tisagenlecleucel in adults with aggressive B-cell non-Hodgkin lymphoma has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression [Phase 3]
Phase 3 trial evaluating haploidentical allogeneic peripheral blood transplantation with analysis of checkpoint immune regulator expression;…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Biochemical Role of Circulating microRNAs Expression as Diagnostic Markers for Non-Hodgkin's Lymphoma Patients
A Sohag University clinical trial is investigating whether circulating microRNAs can serve as diagnostic biomarkers for Non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Study of TG-1701, an Irreversible Bruton's Tyrosine Kinase Inhibitor, in Patients With B-Cell Malignancies [Phase 1]
Clinical Trial Update reports the termination of a Phase 1 study of TG-1701 in B-cell malignancies.
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders [Phase 1]
Phase 1 trial update on T-allo10 for hematopoietic stem cell transplantation in various blood disorders; the NCT03198234 study sponsored by …
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia) [Phase 2]
Phase 2 clinical trial update on LOXO-305 (pirtobrutinib) in Chinese participants with B-cell malignancies, with results posted on July 16, …
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma [Phase 1]
This clinical trial update reports on a Phase 1 study evaluating UTAA09 injection for recurrent or refractory B-cell non-Hodgkin's lymphoma;…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers [NA]
This clinical trial update indicates the study evaluating cardiac rehabilitation for patients receiving radiation therapy for thoracic cance…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1]
DCR-MYC, an investigational therapy, was evaluated in a Phase I multicenter dose-escalation study in patients with solid tumors, multiple my…
-
EMA withdrawal · 2024-07-10EMA Expired: Pixuvri (pixantrone dimaleate) — Les Laboratoires Servier
The EMA has expired the marketing authorization for Pixuvri (pixantrone dimaleate) by Les Laboratoires Servier, effectively withdrawing its …
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide [Phase 2]
Phase 2 haploidentical stem cell transplantation trial using post-transplant cyclophosphamide was terminated.
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma [NA]
This document provides an update on a clinical trial evaluating whole-body diffusion-weighted MRI for staging and predicting treatment respo…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL [Phase 1]
Phase 1 trial results for FT596 CAR-T cells with Rituximab as relapse prevention after autologous HSCT in non-Hodgkin lymphoma were posted, …
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies [Phase 1, Phase 2]
GIC-102, an intravenously administered allogeneic NK cell therapy, is being evaluated in Phase 1/Phase 2 trials for advanced solid tumors an…
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: CD34+ Selected ASCT for Aggressive Lymphomas [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating CD34+ selected autologous stem cell transplantation for aggressive…
-
CLINICAL_TRIALS withdrawal · 2024-07-08Clinical Trial Update: GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma [Phase 1, Phase 2]
The GEMHDM2014 trial evaluating Gem-HDM HDT and autologous stem cell transplant for relapsed/refractory lymphoma has been terminated after P…